271 related articles for article (PubMed ID: 36654948)
1. Establishment and verification of a nomogram to predict tumor-specific mortality risk in triple-negative breast cancer: a competing risk model based on the SEER cohort study.
Li Z; Shi Y; Wu L; Zhang H; Xue J; Li W; Wang X; Zhang L; Wang Q; Duo L; Wang M; Wang G
Gland Surg; 2022 Dec; 11(12):1961-1975. PubMed ID: 36654948
[TBL] [Abstract][Full Text] [Related]
2. Construction and validation of nomogram for the cancer-specific mortality for HER2-positive breast cancer patients.
Wu N
Medicine (Baltimore); 2024 Mar; 103(11):e37330. PubMed ID: 38489717
[TBL] [Abstract][Full Text] [Related]
3. Predicting cancer-specific mortality in T1/2 hepatocellular carcinoma after radiofrequency ablation by competing risk nomogram: A population-based analysis.
He Q; Xiong Y; Xia P; Yang X; Yu Y; Chen Z
Clin Res Hepatol Gastroenterol; 2024 Feb; 48(2):102283. PubMed ID: 38219821
[TBL] [Abstract][Full Text] [Related]
4. Nomogram for Predicting Lymph Node Involvement in Triple-Negative Breast Cancer.
Cui X; Zhu H; Huang J
Front Oncol; 2020; 10():608334. PubMed ID: 33344259
[TBL] [Abstract][Full Text] [Related]
5. Nomogram model for predicting cancer-specific mortality in patients with early-onset colorectal cancer: a competing risk analysis insight from the SEER database and an external validation cohort.
Fu X; Chen Y; Fan Z; Wang W; Wang Z; Yin H; Li J; Guo S
Transl Cancer Res; 2024 Apr; 13(4):1665-1684. PubMed ID: 38737689
[TBL] [Abstract][Full Text] [Related]
6. Prognosis of Patients With Triple-negative Breast Cancer: A Population-based Study From SEER Database.
Zhou HL; Chen DD
Clin Breast Cancer; 2023 Apr; 23(3):e85-e94. PubMed ID: 36669957
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a prognostic nomogram for predicting cancer-specific survival in patients with metastatic clear cell renal carcinoma: A study based on SEER database.
Huang G; Liao J; Cai S; Chen Z; Qin X; Ba L; Rao J; Zhong W; Lin Y; Liang Y; Wei L; Li J; Deng K; Li X; Guo Z; Wang L; Zhuo Y
Front Oncol; 2022; 12():949058. PubMed ID: 36237316
[TBL] [Abstract][Full Text] [Related]
8. Competing risk nomogram for predicting cancer-specific mortality in patients with non-melanoma skin cancer.
Tang L; Zhang L; Zeng Y; Li Y
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8817-8827. PubMed ID: 37142808
[TBL] [Abstract][Full Text] [Related]
9. Development of a prognostic nomogram for lymph node positive HR
Cheng X; Jiang J; Liang X; Zheng X
Gland Surg; 2023 Nov; 12(11):1541-1553. PubMed ID: 38107492
[TBL] [Abstract][Full Text] [Related]
10. Nomograms predict survival in elderly women with triple-negative breast cancer: A SEER population-based study.
Feng R; Huang W; Liu B; Li D; Zhao J; Yu Y; Cao X; Wang X
Technol Health Care; 2024 Jan; ():. PubMed ID: 38306071
[TBL] [Abstract][Full Text] [Related]
11. Prediction of postoperative survival of triple-negative breast cancer based on nomogram model combined with expression of HIF-1α and c-myc.
Cui J; Jiang H
Medicine (Baltimore); 2019 Oct; 98(40):e17370. PubMed ID: 31577739
[TBL] [Abstract][Full Text] [Related]
12. Construction and validation of a nomogram for predicting the prognosis of patients with lymph node-positive invasive micropapillary carcinoma of the breast: based on SEER database and external validation cohort.
Li Y; Liu J; Xu Z; Shang J; Wu S; Zhang M; Liu Y
Front Oncol; 2023; 13():1231302. PubMed ID: 37954073
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and Prognostic Nomograms for Lung Metastasis in Triple-Negative Breast Cancer.
Wang J; Zhao H; Ye L; Li J; Zhang H; Zhang C; Rao Q; Cai Y; Xu Y; Deng Y
Comput Math Methods Med; 2022; 2022():1750834. PubMed ID: 35991145
[TBL] [Abstract][Full Text] [Related]
14. A Web-based Prediction Model for Early Death in Patients With Metastatic Triple-negative Breast Cancer.
Pan WK; Ren SY; Zhu LX; Lin BC
Am J Clin Oncol; 2024 Feb; 47(2):71-80. PubMed ID: 37871164
[TBL] [Abstract][Full Text] [Related]
15. Risk Stratification Model for Predicting the Overall Survival of Elderly Triple-Negative Breast Cancer Patients: A Population-Based Study.
Liu X; Yue S; Huang H; Duan M; Zhao B; Liu J; Xiang T
Front Med (Lausanne); 2021; 8():705515. PubMed ID: 34621757
[No Abstract] [Full Text] [Related]
16. Development and validation of a Surveillance, Epidemiology, and End Results (SEER)-based prognostic nomogram for predicting survival in gastric cancer with multi-organ metastases.
Wang T; Liu C; Wang W; Huang B; Yu R; Huang M; Dong W
Transl Cancer Res; 2022 Jun; 11(6):1534-1551. PubMed ID: 35836507
[TBL] [Abstract][Full Text] [Related]
17. Nomogram for predicting preoperative regional lymph nodes metastasis in patients with metaplastic breast cancer: a SEER population-based study.
Zhang M; Wang B; Liu N; Wang H; Zhang J; Wu L; Zhao A; Wang L; Zhao X; Yang J
BMC Cancer; 2021 May; 21(1):565. PubMed ID: 34001061
[TBL] [Abstract][Full Text] [Related]
18. Nomogram for predicting overall survival in patients with triple-negative apocrine breast cancer: Surveillance, epidemiology, and end results-based analysis.
Xu Y; Zhang W; He J; Wang Y; Chen R; Shi W; Wan X; Shi X; Huang X; Wang J; Zha X
Breast; 2022 Dec; 66():8-14. PubMed ID: 36084385
[TBL] [Abstract][Full Text] [Related]
19. Survival outcome assessment for triple-negative breast cancer: a nomogram analysis based on integrated clinicopathological, sonographic, and mammographic characteristics.
Sheng DL; Shen XG; Shi ZT; Chang C; Li JW
Eur Radiol; 2022 Oct; 32(10):6575-6587. PubMed ID: 35759017
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a prognostic nomogram for colorectal cancer after surgery.
Li BW; Ma XY; Lai S; Sun X; Sun MJ; Chang B
World J Clin Cases; 2021 Jul; 9(21):5860-5872. PubMed ID: 34368305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
